CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,840 | $564.87 | $1.0M | 42,932 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,259 | $566.02 | $1.3M | 40,673 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $566.42 | $91K | 40,513 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 183,410 | ||
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +300 | $146.03 | $44K | 45,472 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,000 | $146.03 | $1.2M | 53,472 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −110 | $555.72 | $61K | 53,362 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −10 | $556.70 | $6K | 53,352 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −640 | $557.85 | $357K | 52,712 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $559.99 | $112K | 52,512 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,178 | $561.99 | $1.2M | 50,334 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,326 | $562.93 | $746K | 49,008 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,015 | $564.06 | $1.1M | 46,993 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,251 | $565.20 | $707K | 45,742 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −270 | $566.05 | $153K | 45,472 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −300 | $562.50 | $169K | 45,172 |
| 2026-05-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 113,940 | ||
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $562.01 | $247K | 49,573 |
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,071 | $562.94 | $1.2M | 47,502 |
Page 98 of 120 · 2,391 trades